International Progressive MS Alliance awards €6.9 million to three studies researching therapies to address common symptoms of progressive MS
The International Progressive MS Alliance has awarded €6.9 million to three global studies aimed at finding solutions for the most common symptoms experienced by people living with progressive MS, including fatigue, cognitive impairment, pain and mobility.
The Well-Being Phase II Efficacy Awards are part of the Alliance’s overall Well-being Research Pipeline, a large, multi-stage initiative to design, test and implement innovative approaches to solve some of the most difficult aspects of living with progressive MS.
The three projects include:
Comparison of Self-Guided, Coached and Therapist-Delivered Pain Self-Management ...